Long-Term Results of Riboflavin UV A Corneal Cross-Linking for Keratoconus
Author Information
Author(s): Caporossi Aldo, Mazzotta Cosimo, Baiocchi Stefano, Caporossi Tomaso, Denaro Rosario
Primary Institution: University of Siena
Hypothesis
Does Riboflavin UV A corneal cross-linking improve long-term functional outcomes in patients with progressive keratoconus across different age groups?
Conclusion
Riboflavin UV A cross-linking is effective in stabilizing keratoconus, especially in patients under 26 years old.
Supporting Evidence
- Over 90% of treated patients experienced long-term stabilization of keratoconus.
- Paediatric patients showed the best functional improvement after treatment.
- Statistical analysis indicated significant improvements in visual acuity across all age groups.
Takeaway
This study shows that a special eye treatment helps people with a condition called keratoconus see better, especially if they are younger.
Methodology
The study involved a comparative prospective analysis of 516 eyes from patients aged 10 to 40 years with progressive keratoconus, treated with Riboflavin UV A cross-linking.
Potential Biases
There may be a risk of bias due to the nonrandomized nature of the study.
Limitations
The study had a small number of patients in the longitudinal analysis after 24 months, which may affect the statistical significance of some results.
Participant Demographics
Patients aged between 10 and 40 years, with a male/female ratio of 4:1 overall.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website